Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Meds Apotek AB (publ)FRA:24R +17.68%11 Days Payable is 47.32 as of Jun. 2026, which is 5% below its 10-year median of 49.58. GuruFocus rates FRA:24R with a GF Score™ of 11/100. The stock has 2 warning signs investors should review. Among 1,103 Retail - Cyclical companies, Meds Apotek AB (publ) ranks better than 67.82% on this metric.
Meds Apotek AB (publ) Days Payable Historical Data
* Premium members only.
The historical data trend for Meds Apotek AB (publ)'s Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:24R vs AMZN, BABA, PDD: Days Payable Comparison
For the Internet Retail subindustry, Meds Apotek AB (publ)'s Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Meds Apotek AB (publ) Days Payable vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, Meds Apotek AB (publ)'s Days Payable distribution charts can be found below:
* The bar in red indicates where Meds Apotek AB (publ)'s Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Meds Apotek AB (publ)'s Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Meds Apotek AB (publ) (FRA:24R) has a Days Payable of 47.32 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Meds Apotek AB (publ) and its competitors. This is near median its historical median of 49.58. Over the past decade, Meds Apotek AB (publ)'s Days Payable has ranged from 48.89 to 77.28. According to the industry distribution chart, Meds Apotek AB (publ) ranks #355 out of 1103 companies in the Retail - Cyclical industry, placing it in the top 32.2%.
Is Meds Apotek AB (publ)'s Days Payable too high?
Meds Apotek AB (publ)'s current Days Payable of 47.32 is near median its 10-year median of 49.58. Over the past 10 years, this metric has ranged from a low of 48.89 to a high of 77.28. The Retail - Cyclical industry median Days Payable is 51.47. Meds Apotek AB (publ)'s value of 47.32 is 8.1% below this industry median. Based on the distribution chart, Meds Apotek AB (publ) ranks #355 out of 1103 companies in the Retail - Cyclical industry, which is above the industry midpoint. Overall, Meds Apotek AB (publ) has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Meds Apotek AB (publ)'s Days Payable compare to AMZN and BABA?
According to the Retail - Cyclical industry distribution chart, Meds Apotek AB (publ) ranks #355 out of 1103 companies for Days Payable. This puts Meds Apotek AB (publ) in the upper half of its industry. The industry median Days Payable is 51.47. Meds Apotek AB (publ)'s value of 47.32 is 8.1% below this benchmark. Historically, Meds Apotek AB (publ)'s own Days Payable has ranged from 48.89 to 77.28 over the past decade. While the company's 10-year median is 49.58 vs. the industry median of 51.47, Meds Apotek AB (publ) has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Retail - Cyclical company?
The median Days Payable among Retail - Cyclical companies is 51.47, based on 1,103 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Meds Apotek AB (publ)'s current Days Payable of 47.32 is 8.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Meds Apotek AB (publ) and its competitors. For the Retail - Cyclical industry, the median Days Payable is 51.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Meds Apotek AB (publ)'s current Days Payable is 47.32, which is near median its own 10-year median of 49.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Meds Apotek AB (publ) stock overvalued right now?
Meds Apotek AB (publ) (FRA:24R) has a current Days Payable of 47.32. The current Days Payable is 47.32, which is near median its 10-year median of 49.58 and 8.1% below the Retail - Cyclical industry median of 51.47. Meds Apotek AB (publ)'s overall GF Score™ is 11/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Meds Apotek AB (publ) (FRA:24R), the current Days Payable is 47.32 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Meds Apotek AB (publ) is a full-scale online pharmacy that sells prescription and over-the-counter medicines with permission from the Medical Products Agency, the Swedish Food Agency and the E-Health Agency. The company's pharmacy products include everything in health, well-being, dietary supplements, beauty products, children's products, fitness products, food and drink and home & household products.
11GF Score
Get the complete analysis for FRA:24R
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:24R has been successfully added to your 
